Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dunky

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Zeitschrift Fur Rheumatologie|March 1, 1991
Complement C3 cleavage product in synovial fluids detected by immunofixationG Partsch, K Bauer, H Bröll, et al.
Journal of Clinical Pharmacy and Therapeutics|April 26, 2006
Short-term infliximab therapy improves symptoms of psoriatic arthritis and decreases concentrations of cartilage oligomeric matrix proteinE Cauza, U Hanusch-Enserer, K Frischmuth, et al.
Acta Medica Austriaca|March 23, 2001
[Serum soluble CD44 isoform variant 5 level in patients with seropositive rheumatoid arthritis treated with cyclosporin A]J Feyertag, G Haberhauer, M Skoumal, et al.
European Journal of Clinical Investigation|November 30, 2005
Strength and endurance training lead to different post exercise glucose profiles in diabetic participants using a continuous subcutaneous glucose monitoring systemE Cauza, U Hanusch-Enserer, B Strasser, et al.
Clinical and Experimental Rheumatology|December 9, 1998
Soluble CD44-isoform variant-5 (sCD44v5) in psoriatic arthritisG Haberhauer, E M Kittl, K Bauer, et al.
Rheumatology International|February 18, 2006
Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatmentM Skoumal, G Haberhauer, J Feyertag, et al.
International Journal of Clinical Pharmacology Research|January 1, 1989
Methotrexate serum-level determinations during low-dose therapy of rheumatoid and psoriatic arthritisB Leeb, A Dunky, E Ogris, et al.
International Journal of Tissue Reactions|January 1, 1988
The influence of synovial fluids from patients with rheumatic diseases on chick embryo fibroblastsG Partsch, P Petera, A Dunky, et al.
The Journal of Rheumatology|March 1, 1997
Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluidG Partsch, G Steiner, B F Leeb, et al.
Annals of the Rheumatic Diseases|January 30, 1999
T cell derived cytokines in psoriatic arthritis synovial fluidsG Partsch, E Wagner, B F Leeb, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Zeitschrift Fur Rheumatologie|March 1, 1991
Complement C3 cleavage product in synovial fluids detected by immunofixationG Partsch, K Bauer, H Bröll, et al.
Journal of Clinical Pharmacy and Therapeutics|April 26, 2006
Short-term infliximab therapy improves symptoms of psoriatic arthritis and decreases concentrations of cartilage oligomeric matrix proteinE Cauza, U Hanusch-Enserer, K Frischmuth, et al.
Acta Medica Austriaca|March 23, 2001
[Serum soluble CD44 isoform variant 5 level in patients with seropositive rheumatoid arthritis treated with cyclosporin A]J Feyertag, G Haberhauer, M Skoumal, et al.
European Journal of Clinical Investigation|November 30, 2005
Strength and endurance training lead to different post exercise glucose profiles in diabetic participants using a continuous subcutaneous glucose monitoring systemE Cauza, U Hanusch-Enserer, B Strasser, et al.
Clinical and Experimental Rheumatology|December 9, 1998
Soluble CD44-isoform variant-5 (sCD44v5) in psoriatic arthritisG Haberhauer, E M Kittl, K Bauer, et al.
Rheumatology International|February 18, 2006
Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatmentM Skoumal, G Haberhauer, J Feyertag, et al.
International Journal of Clinical Pharmacology Research|January 1, 1989
Methotrexate serum-level determinations during low-dose therapy of rheumatoid and psoriatic arthritisB Leeb, A Dunky, E Ogris, et al.
International Journal of Tissue Reactions|January 1, 1988
The influence of synovial fluids from patients with rheumatic diseases on chick embryo fibroblastsG Partsch, P Petera, A Dunky, et al.
The Journal of Rheumatology|March 1, 1997
Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluidG Partsch, G Steiner, B F Leeb, et al.
Annals of the Rheumatic Diseases|January 30, 1999
T cell derived cytokines in psoriatic arthritis synovial fluidsG Partsch, E Wagner, B F Leeb, et al.
Pageof 6